22nd Century Group Inc (XXII)

$XXII Welcome noobs, great earnings, buy all you can, cry later.

$XXII Recent Business Highlights

$XXII uh oh.

$XXII I'm bored in my mother's basement, Monsieur Arch.

$XXII 22nd Century Group, Inc. Pioneering a New Era in Tobacco Products

$XXII you bots are malfunctioning and posting the same exact crap as each other. Run it through an LLM and spice it up a little for us, will ya?

$XXII 22nd Century Group Reports Second Quarter 2026 Financial Results 💥 2026 Strategic Priorities 22nd Century has identified the below priorities for its business activities in 2026: ✔ - Expanding VLN® product distribution and consumer awareness. ✔ - Continuing disciplined cost management and capital allocation. ✔ - Advancing toward EBITDA breakeven as higher-margin revenues scale. ✔- Remaining actively engaged with FDA regulators and public-health stakeholders. Link to the 8am Webcast on Q2 Results https://event.choruscall.com/mediaframe/webcast.html?webcastid=Ec6efNWK Full News & Disclaimer https://www.globenewswire.com/news-release/2026/08/13/3344301/0/en/22nd-century-group-reports-second-quarter-2026-financial-results.html

$XXII Awesome CC

$XXII 10 Reasons Why (NASDAQ: XXII) Could be Our Most Explosive Find Yet https://marketwirenews.com/alerts/xxii/ ⚡ FDA Authorization The company's VLN® cigarettes are the only commercially available combustible low nicotine products authorized by the FDA in the United States. This endorsement underscores the scientific backing and regulatory acceptance of their innovative products. ℹ Leadership in Tobacco Harm Reduction 22nd Century Group has established itself as a pioneer in the tobacco harm reduction movement, advocating for less harmful alternatives to traditional smoking, thereby enhancing its reputation and market positioning. 💥 Proprietary Technology Their patented non-GMO reduced nicotine tobacco plants enable production of tobacco products with 95% less nicotine than traditional alternatives, showcasing their commitment to innovation and quality. ℹ Expanding Product Portfolio The introduction of new products like Pinnacle VLN® and Pinnacle Pure allows 22nd Century to meet diverse consumer needs, broaden its market reach, and enhance revenue opportunities through product differentiation. 📈 Strategic Market Penetration The recent launch of Pinnacle VLN® products in states like Like California, New York and New Jersey, one of the largest tobacco markets in the U.S., indicates strong growth potential and strategic foresight in targeting regions with supportive tobacco policy environments. 💵 Growth Trajectory and Economic Potential With increasing retailer interest and anticipated high-margin contributions from new product launches, 22nd Century is well-positioned to capitalize on market trends towards smoking alternatives, translating to potential revenue growth and stronger market performance for investors. 💪 Strong Consumer Demand Early metrics from their recent product launches indicate an increasing base of VLN® smokers, reflecting a growing consumer interest in reduced nicotine options and the effectiveness of their market strategies. ℹ Robust Marketing Strategy The appointment of Katherine Rouse-Bailey as Vice President of Marketing signals a renewed focus on brand-building and consumer engagement, aimed at increasing trial and repeat purchases of their products. ✔ Extensive Patent Portfolio 22nd Century's broad intellectual property portfolio enhances its competitive advantage by safeguarding its technology and providing a framework for ongoing innovation in the tobacco product space. ℹ Positive Public Impact Scientific studies supporting their product claims demonstrate that reduced nicotine consumption can lead to lower tobacco dependence, positioning the company as a socially responsible choice for consumers looking cut down on smoking.